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Abstract
We conducted a meta-analysis of studies examining the association between the Val158Met COMT polymorphism and
violence against others in schizophrenia. A systematic search current to November 1, 2011 was conducted using MEDLINE,
EMBASE, CINAHL, PsycINFO, ProQuest, and the National Criminal Justice Reference Service and identified 15 studies
comprising 2,370 individuals with schizophrenia for inclusion. Bivariate analyses of study sensitivities and specificities were
conducted. This methodology allowed for the calculation of pooled diagnostic odds ratios (DOR). Evidence of a significant
association between the presence of a Met allele and violence was found such that men’s violence risk increased by
approximately 50% for those with at least one Met allele compared with homozygous Val individuals (DOR= 1.45; 95%
CI = 1.05–2.00; z= 2.37, p= 0.02). No significant association between the presence of a Met allele and violence was found for
women or when outcome was restricted to homicide. We conclude that male schizophrenia patients who carry the low
activity Met allele in the COMT gene are at a modestly elevated risk of violence. This finding has potential implications for
the pharmacogenetics of violent behavior in schizophrenia.
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Introduction
Schizophrenia elevates the risk of violent behavior [1]. Violence
risk is a frequent reason for hospital admission, delays hospital
discharge, complicates patient care, increases caregiver burden,
leads to arrest and incarceration, and thus increases the stigma as
well as the financial cost of the disease. For these reasons, violence
in schizophrenia constitutes a major public health concern [2].
Violence is a complicated phenomenon that results from the
interaction between many biological and social factors. Although
serotonin is the principal neurotransmitter in the regulation of
violence, dopamine and noradrenaline are also involved [3].
Enhancement of central dopaminergic or noradrenergic function
facilitates aggressive behavior in most (but not all) animal studies
[4]. Drugs that increase central dopaminergic transmission, such
as amphetamines and cocaine, may elicit psychosis with violent
behavior [2]. Furthermore, drugs that diminish noradrenergic
activity (such as propranolol) have antiaggressive effects in humans
[5,6]. Thus, the preponderance of the evidence suggests that
catecholamines generally enhance violence.
Catechol-O-methyltransferase (COMT) is one of the enzymes
responsible for the catabolism of dopamine and noradrenaline in
the brain. A common biallelic single nucleotide polymorphism,
involving a Val (valine) to Met (methionine) substitution at codon
158 of the COMT gene (rs4680) has been identified and localized
to chromosome 22q11.1-q11.2 [7]. The Val allele at this locus is
associated with high enzymatic activity, whereas the Met allele is
associated with low enzymatic activity. Homozygosity for the Met
allele yields a 3- to 4-fold reduction in COMT activity relative to
Val homozygotes, with heterozygotes demonstrating intermediate
activity.
Male heterozygous COMT knockout mice have been shown to
exhibit increased aggressive behavior [8]. When eight mouse
strains were ranked according to their aggressivity, the ranking
correlated with the expression of the COMT gene in the
hippocampus: the lower the level of expression, the more
aggressive the strain [9]. (Expression was assessed by quantifying
the mRNA, genotypes were not reported [9]).
Thus, consistent with the enhancing effects of catecholamines
on aggression, low expression of the COMT is associated with
increased aggression in animal models. Based on the findings
discussed above, it would seem appropriate to hypothesize that, in
general, the COMT polymorphism would exert an effect in
humans such that the Met allele would be associated with
increased violent behavior. This would also be expected in
schizophrenia patients. However, the original reason for COMT
genotyping in these patients was to study association between this
genotype and the diagnosis of schizophrenia rather than violence.
Serendipitously, it was noted that the Met allele was associated
with dangerousness [10], rather than with the diagnosis of
schizophrenia [11].
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Subsequent studies of violence and the COMT polymorphism
in schizophrenia were conducted to replicate and expand these
findings. The studies were heterogeneous in diagnoses and
outcome variables. The samples included patients with schizo-
phrenia, schizoaffective disorder, delusional disorder, and other
diagnoses. The outcome variables combined physical violence
against others with self-harm, violence against objects, verbal
aggression, and threats. These differences make the findings of
available studies difficult to compare directly, and may be
responsible for their conflicting results. We present a meta-analysis
of these studies focused on one diagnosis (schizophrenia) and one
outcome (physical violence against others).
Methods
Study protocol
The Preferred Reporting Items for Systematic Reviews and
Meta-analyses (PRISMA) Statement [12], a 27-item checklist of
review characteristics, was followed to enable a transparent and
consistent reporting of results.
Systematic search
A systematic search current to November 1, 2011 was
conducted using MEDLINE, EMBASE, CINAHL, PsycINFO,
ProQuest, and National Criminal Justice Reference Service
Abstracts with the following keywords: Val158Met, Val(158)Met,
158 Val/Met, and rs4680. Additional articles were located through
reference lists, annotated bibliographies, and discussion with
experts. Studies in all languages and those not published in
academic journals were considered. Studies were included if their
titles, abstracts, or methods sections demonstrated testing of the
association between the Met allele of the Val158Met poly-
morphism of the COMT gene and physical violence against
others in schizophrenia.
The initial search identified a total of 2,018 records (Figure 1).
The number of records was reduced to 413 when abstracts were
scrutinized to see whether they were relevant to individuals with
schizophrenia. When editorials, reviews, and reports were
excluded that did not use physical violence against others as an
outcome, 17 independent studies remained.
Inclusion in the meta-analysis required that the number of
participants with Val/Val, Val/Met, and Met/Met genotypes be
available, as well as the number of individuals within each
genotype that engaged in physical violence against others. Such
tabular data were either available in the manuscript or obtained
directly from authors for 15 (88.2%) of the 17 eligible studies, 14
(93.3%) of which also contributed specific information on
homicide as an outcome, and 13 (86.7%) of which contributed
outcome data separately for men and women. As this data
concerned only those participants diagnosed with schizophrenia
and the published data often included persons with other
schizophrenia-spectrum disorders, the sample sizes, number of
participants with each genotype, and base rates of violence used in
the present review often differ from those published in the original
Figure 1. Systematic search for studies investigating the association between the Val158Met COMT polymorphism and violence.
doi:10.1371/journal.pone.0043423.g001
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manuscripts. The two studies for which tabular data were
unobtainable [10,13] were excluded from analyses. Thus, a total
of 15 studies were included.
Data extraction
JS extracted 39 demographic and descriptive characteristics
from each of the included studies. As a measure of quality control,
five (33.3%) of the studies were randomly selected and coded by
a second investigator (PC). A high level of inter-rater agreement
was established (k= 0.93), and disagreements were settled by
consensus [14].
Meta-analysis
Following current Cochrane Collaboration guidance [15],
bivariate analyses of study sensitivities (the proportion of violent
individuals classified as ‘‘high risk’’) and specificities (the pro-
portion of non-violent individuals classified as ‘‘low risk’’) were
conducted, accounting for correlation between these study values
[16]. This methodology offered an alternative parameterization of
the hierarchical summary receiver operating characteristic
(HSROC) model [17], and allowed for the identification of
a summary operating point from which pooled diagnostic odds
ratios (DOR; the ratio of the odds of a true positive relative to the
odds of a false positive) were calculated along with pooled
sensitivities and specificities. The DOR is not only an appropriate
effect size when a specific diagnostic marker or test is used to
detect the presence of an adverse state (e.g., using a mammogram
to detect breast cancer), but also in general contexts such as the
present meta-analysis where the association between dichotomous
independent and dependent variables is tested (see Genotypic
comparisons) [18]. When the latter conditions are met, the DOR
is equivalent to the odds ratio obtained using logistic regression
[18]. The percentage of variation across study DORs not due to
chance alone was estimated using the I2 index [19]. As the
HSROC model estimates summary DORs using a different
parameterization than the traditional Mantel-Haenzel and
DerSimonian-Laird models, summary ROC curves were con-
structed to graphically display individual study and pooled DORs
rather than forest plots. Diagnostic methodology such as that
employed in the present review has been used in recent meta-
analyses for the investigation of the association between common
SNPs and other complex behaviors such as suicide [20], substance
abuse [21], and antisocial behavior amongst maltreated children
[22].
Genotypic comparisons
The hypothesis that the presence of a single Met allele would
result in elevated violence risk was meta-analytically investigated.
Individuals with Val/Met or Met/Met genotypes were combined
and compared with individuals with the Val/Val genotype. This
approach, adopted a priori, was based on an analogous meta-
analysis of COMT polymorphism and suicide [20], and two
publications included in the current review [23,24].
Two alternative genotypic comparisons were planned a priori to
explore the effect of the Met allele in subsets of participants: First,
heterozygous Val/Met individuals were compared to homozygous
Met/Met individuals to examine whether a dose-response effect
existed. Second, individuals with the Val/Val genotype were
compared to individuals with the Met/Met genotype to examine
whether the Met allele increased violence risk, in the absence of
the potential effects of genetic heterozygosity [25,26].
Table 1. Descriptive characteristics of studies investigating the association between the Met allele of the Val158Met
polymorphism and violence.
Study Country Dx N % Male % Alc % Drug
Mean age in years
(SD)
Gu et al [55] China DSM-IV 584 100 0 0 34.9 (–)
Han et al [23] S Korea DSM-IV 29 100 0 0 26.4 (4.4)
Han et al [24] S Korea DSM-IV 168 100 0 0 38.9 (10.7)
Hong et al [52] S Korea DSM-IV 193 100 – – 39.3 (8.6)
Jones et al [56] UK DSM-IV 180 75.6 – – –
Kim et al [32] S Korea DSM-IV 165 58.2 – – 38.4 (10.1)
Koh et al [57] S Korea DSM-IV 99 85.9 0 0 36.8 (6.9)
Kotler et al [58] Israel ICD-10 92 – – – 44.6 (–)
Lachman et al [7] USA DSM-IV 31 71.0 80.6 80.6 42.6 (8.9)
Liou et al [59] Taiwan DSM-IV 198 47.5 0 0 37.8 (12.1)
Park et al [60] S Korea DSM-IV 103 61.2 – – 42.2 (7.8)
Strous et al [61] Israel DSM-IV 122 77.0 – – –
Tosato et al [33] Italy ICD-10 80 53.8 3.8 1.3 42.1 (12.2)
Xiong et al [31] China CCMD-3 179 100 0 0 33.2 (–)
Zammit et al [62] UK DSM-IV 147 70.7 30.6 23.8 45.4 (13.8)
Note: – = data not obtainable; UK = United Kingdom; S Korea = South Korea; Dx = diagnostic system; DSM-IV = Diagnostic and Statistical Manual of Mental
Disorders (4th edition); ICD-10 = International Classification of Diseases (10th edition); CCMD-3 = Chinese Classification of Mental Disorders; n = sample size; % Male =
percentage of male participants; % Alc = percentage of participants with lifetime diagnoses of alcohol abuse or dependence; % Drug = percentage of participants with
lifetime diagnoses of drug (non-alcohol) abuse or dependence. Total sample sizes and the number of participants within each genotype are not always equivalent to
those that appear in published articles, as only individuals diagnosed with schizophrenia were included in the present review and outcome data could not always be
obtained for all participants.
doi:10.1371/journal.pone.0043423.t001
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Sources of between-study heterogeneity
Random effects metaregression analyses were conducted to
investigate whether sample or study characteristics were associated
with variation in DORs [27]. We explored the moderating
influence of the following: sex, age, substance abuse, time at risk,
study continent of origin, and source of outcome information. Sex
was analyzed as both a continuous (percentage of sample who
were men) and categorical (study data for men vs. women)
variable. Substance abuse (percentage of sample who had lifetime
diagnoses of alcohol or drug abuse), sample age (mean in years),
and time at risk (mean in months) were investigated continuously.
Continent of origin (Asia vs. other) and source of outcome
information (official records only [institutional and/or criminal]
vs. official records and self- or collateral-report) were explored
categorically. It was decided a priori to conduct metaregression
analyses regardless of heterogeneity levels, as current expert
opinion dictates that sources of heterogeneity should be in-
vestigated regardless of between-study variability levels [28].
Assessment of publication bias
Publication bias is assessed routinely using statistical analogues
of funnel plots [29]. In line with current Cochrane Collaboration
guidance [15], we used a recently developed modified linear
regression test, based on the efficient score and its variance [30], to
assess evidence of publication bias. This novel test was selected, as
commonly used tests to detect funnel plot asymmetry have been
shown to result in elevated false positive rates when applied to
binary outcome data. We did not construct a funnel plot, as such
visual tests produce high false positive rates when DORs are used
as outcome measures [15].
A significance level of a= 0.05 was adopted for all analyses.
Results
Descriptive characteristics
Information was collected on 2,370 individuals with schizo-
phrenia from 15 retrospective investigations of the association
between the Val158Met polymorphism of the COMT gene and
physical violence against others. One article [31] was in Chinese
and was therefore translated by a research assistant working
independently of the authors. The average sample size was 158
(SD = 130) participants, with a trend towards predominantly male
samples. An average of 76 (SD = 69) participants per study had
the Val/Val genotype, 62 (SD = 57) the Val/Met genotype, and
20 (SD = 15) the Met/Met genotype, with Hardy-Weinberg
equilibrium achieved in all investigations. Participants were
recruited from inpatient hospitals in 10 (66.7%) studies, from the
community in 1 (6.7%) study, and from both inpatient and
community settings in 4 (26.7%) studies. The average duration of
psychotic symptoms at the time of genotyping was 15.7 years
(SD = 7.7).
Over a mean time at risk of 136.7 (SD = 184.4) months, 951
(40.1%) of the 2 370 participants were violent, with 460 (20.7%)
committing homicide. Six (40.0%) investigations used community
offending as their outcome, whereas one (6.7%) used institutional
offending, and eight (53.3%) used offending in either setting. Four
(26.7%) studies relied upon institutional records to ascertain
whether participants had been violent, 1 (6.7%) relied upon
criminal records, and the remaining 10 (66.7%) used a combina-
tion of institutional and criminal records along with self- and
collateral-report. Whether violent individuals were on antipsy-
chotic medication at the time of their offense was only ascertain-
able from three studies [31–33] with an average of 28.5% (SD
= 2.1%) of participants meeting this criterion. Additional de-
mographic and study design characteristics are provided in
Table 1, and outcome characteristics are reported in Table 2.
Genotypic meta-analyses
Evidence of a significant association between the presence of
a Met allele and violence was found such that men’s violence risk
increased by approximately 50% for those with at least one Met
allele compared with homozygous Val individuals (DOR = 1.45;
95% CI = 1.05–2.00; z = 2.37, p = 0.02; Figure 2). However, the
association was not significant when violence was restricted to
homicide (DOR = 0.96; 95% CI = 0.71–1.30; z = 0.24, p = 0.81),
suggesting the Met allele may be associated with less serious
physical violence. No significant association between the presence
of a Met allele and violence was found for women or when men
and women were combined (Table 3). Further, no significant dose-
response relationships were found when heterozygous individuals
were compared with homozygous Met individuals.
When homozygous individuals were compared, high rates of
specificity (range = 0.72–0.86) were found. While the association
with violence in the pairwise comparison between the Met
homozygous and Val homozygous groups did not reach our
threshold of statistical significance, a clear trend was identified in
the anticipated direction (DOR = 1.63; 95% CI = 0.94–2.82; z
= 1.55, p = 0.06).
Investigation of heterogeneity
Low to moderate levels of between-study heterogeneity were
found, with the upper-limits of all I2 estimate confidence intervals
below 75% [34]. The source of this heterogeneity was investigated
using metaregression (Table 4). Using outcome data for all
participants, a marginally significant trend was found such that in
samples with higher rates of lifetime drug (non-alcohol) abuse,
Figure 2. Hierarchical summary ROC curve predicting violence
in men with at least one Met allele.
doi:10.1371/journal.pone.0043423.g002
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individuals with the Met allele were at higher risk of violence
(b= 0.02, p= 0.09). No statistically significant moderators were
identified using data from the alternative genotypic comparisons.
Investigation of publication bias
No significant evidence of publication bias was found in any of
the genotypic comparison datasets (test of funnel plot asymmetry
p.0.05 in all cases).
Discussion
We conducted a meta-analysis involving 2,370 individuals with
schizophrenia. We were able to use 15 of the 17 (88%) eligible
retrospective investigations that assessed the association between
the Val158Met polymorphism of the COMT gene and physical
violence against others.
Our principal finding is that the presence of one or more Met
alleles in the COMT genotype elevates interpersonal violence risk
in male schizophrenia patients. The Met allele codes for the low
activity form of the enzyme, and thus this finding is consistent with
the report of elevated aggressivity in male COMT knockout mice
[8]. The principal finding is also consistent with the preponder-
ance of other evidence supporting the roles of dopamine and
noradrenaline in the biology of violence.
The role of many other biological factors in violence in
schizophrenia is well documented [35]. Furthermore, the effects of
the rearing environment, various sociodemographic factors,
history of conduct disorder, stress, current psychotic symptoms,
comorbid substance use, comorbid personality disorders, and
factors related to treatment constitute a network of interacting
pathways leading to violence in schizophrenia [36].
Some of these factors may be related to the COMT poly-
morphism. Met/Met homozygotes have been found to be at
significantly increased risk of behavioral and emotional distur-
bances such as impulsiveness and conduct problems at the ages of
7 and 11 years, relative to either heterozygous or homozygous Val
carriers of the Val158Met polymorphism, but only when they
were exposed to maternal stress in utero [37]. Conduct disorder is
a known precursor of violence in schizophrenia [36,38,39].
Patients with ‘‘non-affective psychotic disorder’’ who were Met/
Met homozygotes have been shown to exhibit significantly
increased psychotic and affective reactivity to stress in comparison
to the Val/Met and Val/Val genotypes. In contrast, healthy
controls have not shown this effect of the COMT polymorphism
[40]. Parental violent crime is associated with violent crime in
offspring with schizophrenia, which suggests a role of familial
(genetic or early environmental) factors in this transmission [41].
The molecular basis of this effect has not been explored.
Impulsivity and violence are related to suicide risk in male
schizophrenia patients [42]. Both suicidal [43] and violent [44]
behaviors in schizophrenia respond to clozapine. Suicidal and
violent behaviors share certain neurobiological features [2]. It is
therefore of interest that the Met allele in the COMT genotype
was associated with the history of violent suicide attempts in
schizophrenia patients [45] and with suicide attempts in alcoholics
[46]. These findings are consistent with our results.
Table 3. Investigating the association between the Met allele of the Val158Met polymorphism and violence.
Physical violence against others Homicide only
Genotypic
comparison Effect size All Men Women All Men Women
Val/Met+Met/Met
vs. Val/Val
DOR
(95% CI)
1.20
(0.91–1.59)
1.45*
(1.05–2.00)
0.96
(0.51–1.79)
0.99
(0.76–1.29)
0.96
(0.71–1.30)
0.84
(0.31–2.26)
I2
(95% CI)
49.70
(8.82–72.24)
44.60
(0.01–71.01)
6.30
(0.01–42.62)
0.01
(0.01–41.11)
0.01
(0.01–44.74)
0.01
(0.01–28.35)
Sensitivity
(95% CI)
0.57
(0.48–0.65)
0.54
(0.45–0.64)
0.60
(0.40–0.77)
0.51
(0.44–0.58)
0.47
(0.42–0.53)
0.55
(0.34–0.74)
Specificity
(95% CI)
0.48
(0.39–0.57)
0.55
(0.47–0.62)
0.39
(0.28–0.51)
0.49
(0.40–0.57)
0.52
(0.44–0.60)
0.41
(0.30–0.54)
Met/Met vs. Val/Met DOR
(95% CI)
1.23
(0.85–1.77)
1.09
(0.68–1.74)
1.48
(0.70–3.17)
1.51
(0.91–2.50)
1.09
(0.55–2.18)
2.36
(0.87–6.40)
I2
(95% CI)
30.30
(0.01–62.49)
33.5
(0.01–65.62)
0.01
(0.01–74.32)
0.01
(0.01–46.09)
0.01
(0.01–44.88)
0.01
(0.01–0.02)
Sensitivity
(95% CI)
0.26
(0.19–0.35)
0.22
(0.16–0.30)
0.33
(0.19–0.49)
0.31
(0.20–0.45)
0.25
(0.14–0.39)
0.47
(0.27–0.69)
Specificity
(95% CI)
0.77
(0.72–0.82)
0.79
(0.72–0.85)
0.75
(0.65–0.83)
0.77
(0.71–0.81)
0.77
(0.71–0.82)
0.72
(0.63–0.80)
Met/Met vs. Val/Val DOR
(95% CI)
1.41
(0.86–2.31)
1.63
(0.94–2.82)
1.11
(0.42–2.89)
1.59
(0.80–3.17)
1.06
(0.62–1.83)
2.22
(0.69–7.14)
I
(95% CI)
54.50
(18.45–74.58)
43.40
(0.01–70.48)
0.01
(0.01–42.66)
4.9
(0.01–38.17)
10.3
(0.01–49.06)
0.01
(0.01–49.76)
Sensitivity
(95% CI)
0.25
(0.14–0.40)
0.21
(0.12–0.35)
0.30
(0.11–0.60)
0.28
(0.15–0.47)
0.19
(0.11–0.30)
0.47
(0.27–0.69)
Specificity
(95% CI)
0.81
(0.71–0.88)
0.86
(0.78–0.91)
0.72
(0.57–0.83)
0.80
(0.70–0.87)
0.82
(0.73–0.88)
0.71
(0.54–0.84)
Note: DOR = diagnostic odds ratio; CI = confidence interval. DOR .1 indicates an increase in violence risk in individuals in the first group in the pairwise comparison
with the second. Significance tests only conducted for DORs.
*p ,0.05.
doi:10.1371/journal.pone.0043423.t003
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We were able to obtain limited information regarding patients’
antipsychotic treatment at the time of their violent incidents. Less
than one-third were reported to be receiving such treatment at the
time of their violence, and this may be an over-estimate, given the
fact that at least 40% of schizophrenia patients are non-adherent
to treatment [47]. Our finding is consistent with the general
agreement that schizophrenia patients who are off medication are
at elevated violence risk [2,48–50].
There was a marginal trend for higher violence risk in
individuals with the Met allele in samples with higher rates of
lifetime drug (non-alcohol) abuse. Substance abuse elevates the risk
of violence in schizophrenia [51], and it is possible that this effect is
partially moderated by the COMT polymorphism. However, the
information on substance abuse in the reports we analyzed was
incomplete, and our finding was not statistically significant. This
should be followed up in future prospective studies.
No significant association between the presence of the Met allele
and violence was found when outcome was restricted to homicide.
With a subset of 460 homicide cases in our sample, if the Met allele
were strongly associated with homicide in the population, one
would expect that such an effect would have been detectable in
a subset of this size. Although we cannot exclude the possibility of
a Type II error, it is possible that the genetic underpinning of
homicide is not identical with that of less severe forms of violence.
Specifically, a functional single nucleotide polymorphism (Ala72-
Ser) in the COMT gene has been shown to differentiate
schizophrenia patients who commit homicide [52]. Thus, the lack
of an association between the Met allele and homicide that we
observed may reflect a biological distinctiveness of this specific
criminal behavior in schizophrenia.
The present study has several limitations in addition to the lack
of information on comorbid substance abuse. First, while no
evidence of a significant association between the presence of a Met
allele and violence against others was found in women, this is
based on eight (53.3%) predominantly male samples. Future
studies may wish to further investigate the effect of the Met allele
in women only. A second limitation was that, as detailed
previously, two studies that met inclusion criteria had to be
excluded, as the reports commingled physical violence against
others with other antisocial behaviors. One of these excluded
studies, using 37 patients, reported an association between the Met
allele and generally ‘‘aggressive and antisocial behavior’’ [10]. The
other study, using 70 subjects, reported no association between the
COMT polymorphism and violence, inclusive of verbal aggression
and physical violence against objects [13]. Thus, the results of
these two excluded studies came to different conclusions regarding
the association between the COMT polymorphism and violence.
However, both studies were relatively small, leading us to believe
that their exclusion was not likely to have appreciably affected our
results. A third limitation was that population stratification due to
unmeasured sample-level characteristics may have influenced
effect sizes. Although metaregression was used to explore the
potentially moderating role of geographic location, sex, and age
with no significant findings, future studies may wish to investigate
whether additional characteristics such as immigrant status and
parental country of origin influence the association between the
presence of the Met allele and violence in schizophrenia.
The principal strength of our meta-analysis is its narrow focus.
We have limited the diagnosis to schizophrenia, and the behavior
of interest to physical violence against others. Self-harm, violence
against objects, verbal aggression, as well as threats and other
antisocial behaviors were excluded. These behaviors have often
been commingled with physical violence in previous studies. One
of the reasons for variability in the findings of past studies of this
Table 4. Metaregression analyses examining sources of heterogeneity in studies investigating the association between the Met
allele of the Val158Met polymorphism and violence.
Physical violence against others Homicide only
All Men Women All Men Women
Sample or study characteristic b (SE) b (SE) b (SE) b (SE) b (SE) b (SE)
Sex
% Men 0.01 (0.01) – – 0.01 (0.02) – –
Men vs. Womena 0.14 (0.10) – – 0.07 (0.13) – –
Mean age (years)
Continuous 0.01 (0.03) – – –0.02 (0.05) – –
Substance abuse
% Alcohol abuse 0.02 (0.01) – – – – –
% Drug abuse 0.02 (0.01) – – – – –
Mean time at risk (months)
Continuous 0.01 (0.01) – – –0.01 (0.01) – –
Continent of origin
Asia vs. Other 0.12 (0.33) .59 (0.40) 0.64 (0.61) –0.34 (0.51) –0.90 (0.77) –1.42 (1.00)
Source of outcome
Official records onlyb vs. Other –0.01 (0.32) 0.05 (0.35) 0.38 (0.59) –0.42 (0.27) –0.39 (0.30) –0.76 (0.99)
Note: SE = standard error; – = analysis not applicable or data not available. Diagnostic odds ratios from the Val/Val vs. Val/Met + Met/Met comparison were used. The
moderating role of sample ethnic composition was not investigated due to low levels of within-study ethnic diversity, resulting in overlap with continent of origin. No
evidence of significant moderation was found (p .0.05 in all cases).
aStudy data on men vs. women.
bInstitutional and criminal records.
doi:10.1371/journal.pone.0043423.t004
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type may have been between-study heterogeneity in diagnostic
criteria and the operationalization of violence.
Our findings may have several implications for treatment.
Clozapine is currently the most effective treatment of violent
behavior in schizophrenia patients [44]. Nevertheless, many
patients fail to respond, discontinue the treatment, or experience
prohibitive side effects [53]. Beta-adrenergic blocking agents could
be a suitable alternative or adjunctive treatment in such cases.
Older studies reported encouraging results in violent schizophre-
nia patients [5,6], but the treatment has been virtually abandoned.
This was partly due to the blocking agents’ cardiovascular side
effects, necessitating a slow dose escalation rate, and partly to the
pressure to use newly introduced second generation antipsychotics.
However, if violent behavior is due, in part, to enhanced
noradrenergic activity in some patients with schizophrenia, then
beta-adrenergic blocking agents could be effective in these
particular patients. Theoretically, male patients possessing at least
one Met allele in their COMT genotype should be the suitable
candidates for such treatment. Future randomized controlled trials
of beta-adrenergic blocking agents using COMT genotype as
a predictor variable could test this hypothesis.
Although we have narrowed our violent phenotype as much as
possible given the retrospective nature of our study, future
prospective research is warranted to examine the association
between the Met allele and violence in men with psychosis.
Violence against others in schizophrenia has several subtypes that
differ in their pathogenesis, treatment, and prognosis [39,44,54].
The role of the COMT genotype likely varies across such
subtypes, and this variation should be investigated.
We conclude that male schizophrenia patients who carry the
low activity Met allele in the COMT gene are at a modestly
elevated risk of violence. This finding has potential implications for
the pharmacogenetics of violent behavior in schizophrenia.
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